1. Impact of hyperoxia on patients hospitalized in an intensive care unit for acute heart failure.
- Author
-
Nael J, Ruggiu M, Bailleul C, Ortuno S, Diehl JL, Vimpère D, Augy JL, Guerot E, Danchin N, Puymirat E, and Aissaoui N
- Subjects
- Acute Disease, Aged, Aged, 80 and over, Female, Heart Failure diagnosis, Heart Failure mortality, Hospital Mortality, Humans, Hyperoxia diagnosis, Hyperoxia mortality, Hyperoxia therapy, Length of Stay, Male, Middle Aged, Oxygen Inhalation Therapy mortality, Paris, Patient Readmission, Preliminary Data, Pulmonary Edema diagnosis, Pulmonary Edema mortality, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, Treatment Outcome, Heart Failure therapy, Hyperoxia etiology, Intensive Care Units, Oxygen Inhalation Therapy adverse effects, Patient Admission, Pulmonary Edema therapy
- Abstract
Background: Oxygen therapy remains a cornerstone of treatment for acute heart failure in patients with pulmonary congestion. While avoiding hypoxaemia has long been a goal of critical care practitioners, less attention has been paid to the potential hazard related to excessive hyperoxia., Aim: To evaluate the impact of early hyperoxia exposure among critically ill patients hospitalized in an intensive care unit for acute heart failure., Methods: In this preliminary study conducted in a Parisian intensive care unit, we assessed patients with acute heart failure admitted with pulmonary congestion and treated with oxygen therapy from 1 January 2015 to 31 December 2016. The hyperoxia group was defined by having at least one partial pressure of oxygen measurement>100mmHg on the first day following admission to the intensive care unit. The primary endpoint was 30-day all-cause mortality. Secondary endpoints were 30-day unplanned hospital admissions, occurrence of infections and intensive care unit and hospital lengths of stay., Results: Seventy-five patients were included. Forty-three patients (57.3%) presented hyperoxia, whereas 32 patients (42.7%) did not (control group). The baseline clinical characteristics did not differ between the two groups. The primary endpoint was not statistically different between the two groups (14.0% in the hyperoxia group vs 18.8% in the control group; P=0.85). The secondary endpoints were also not significantly different between the two groups. In the multivariable analysis, hyperoxia was not associated with increased 30-day mortality (odds ratio 0.77, 95% confidence interval 0.24-2.41)., Conclusion: In patients referred to an intensive care unit for acute heart failure, we did not find any difference in outcomes according to the presence of hyperoxia., (Copyright © 2019 Elsevier Masson SAS. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF